PARIS, May 12 (Reuters) - U.S. pharmaceutical and healthcare giant Pfizer announced on Sunday a 500 million-euro ($538 million) investment in France for research and development, ahead of the start of this year's annual 'Choose France' business summit. ($1 = 0.9286 euros) (Reporting by Sudip Kar-Gupta and Elizabeth Pineau; Editing by Hugh Lawson)
Market Closed -
Other stock markets
|
After market 08:00:00 pm | |||
28.3 USD | -2.01% | 28.1 | -0.71% |
May. 27 | US, European nations consider vaccinating workers exposed to bird flu | RE |
May. 24 | Novavax awaits FDA decision on whether its next COVID shot can be offered in US | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.70% | 160B | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.26% | 238B | |
+7.16% | 204B | |
-6.22% | 203B | |
+4.23% | 161B | |
-2.01% | 120B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer announces 500 million euros investment in France